226 related articles for article (PubMed ID: 17276699)
1. Metabolic mapping using 2D 31P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia.
Smesny S; Rosburg T; Nenadic I; Fenk KP; Kunstmann S; Rzanny R; Volz HP; Sauer H
Neuroimage; 2007 Apr; 35(2):729-37. PubMed ID: 17276699
[TBL] [Abstract][Full Text] [Related]
2. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla.
Jensen JE; Miller J; Williamson PC; Neufeld RW; Menon RS; Malla A; Manchanda R; Schaefer B; Densmore M; Drost DJ
Psychiatry Res; 2006 Mar; 146(2):127-35. PubMed ID: 16497488
[TBL] [Abstract][Full Text] [Related]
3. Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy study.
Weber-Fahr W; Englisch S; Esser A; Tunc-Skarka N; Meyer-Lindenberg A; Ende G; Zink M
Psychiatry Res; 2013 Dec; 214(3):365-73. PubMed ID: 24045051
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic drug effects on left prefrontal phospholipid metabolism: a follow-up 31P-2D-CSI study of haloperidol and risperidone in acutely ill chronic schizophrenia patients.
Smesny S; Langbein K; Rzanny R; Gussew A; Burmeister HP; Reichenbach JR; Sauer H
Schizophr Res; 2012 Jul; 138(2-3):164-70. PubMed ID: 22516552
[TBL] [Abstract][Full Text] [Related]
5. [31P-MR spectroscopy of the brain in patients with anorexia nervosa: characteristic differences in the spectra between patients and healthy control subjects].
Rzanny R; Freesmeyer D; Reichenbach JR; Mentzel HJ; Pfleiderer SO; Klemm S; Gerhard UJ; Blanz B; Kaiser WA
Rofo; 2003 Jan; 175(1):75-82. PubMed ID: 12525985
[TBL] [Abstract][Full Text] [Related]
6. Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study.
Keshavan MS; Stanley JA; Montrose DM; Minshew NJ; Pettegrew JW
Mol Psychiatry; 2003 Mar; 8(3):316-23, 251. PubMed ID: 12660804
[TBL] [Abstract][Full Text] [Related]
7. [Magnetic resonance spectroscopy in schizophrenia].
Delamillieure P; Constans JM; Fernandez J; Dollfus S
Encephale; 2000; 26(1):21-31. PubMed ID: 10875059
[TBL] [Abstract][Full Text] [Related]
8. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease.
Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH
Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496
[TBL] [Abstract][Full Text] [Related]
9. Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients.
Smesny S; Gussew A; Biesel NJ; Schack S; Walther M; Rzanny R; Milleit B; Gaser C; Sobanski T; Schultz CC; Amminger P; Hipler UC; Sauer H; Reichenbach JR
Schizophr Res; 2015 Oct; 168(1-2):322-9. PubMed ID: 26255566
[TBL] [Abstract][Full Text] [Related]
10. In vivo brain (31)P-MRS: measuring the phospholipid resonances at 4 Tesla from small voxels.
Jensen JE; Drost DJ; Menon RS; Williamson PC
NMR Biomed; 2002 Aug; 15(5):338-47. PubMed ID: 12203225
[TBL] [Abstract][Full Text] [Related]
11. 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism.
Yacubian J; de Castro CC; Ometto M; Barbosa E; de Camargo CP; Tavares H; Cerri GG; Gattaz WF
Schizophr Res; 2002 Dec; 58(2-3):117-22. PubMed ID: 12409151
[TBL] [Abstract][Full Text] [Related]
12. MRI volumetric and 31P MRS metabolic correlates of caudate nucleus in antipsychotic-naïve schizophrenia.
Jayakumar PN; Venkatasubramanian G; Keshavan MS; Srinivas JS; Gangadhar BN
Acta Psychiatr Scand; 2006 Nov; 114(5):346-51. PubMed ID: 17022794
[TBL] [Abstract][Full Text] [Related]
13. [Spectroscopic imaging of the human liver using 3D CSI: optimization and application in patients with metastatic uvea melanoma].
Beer M; Winkelmann V; Becker JC; Terheyden P; Stenzel M; Bröcker EB; Hahn D; Köstler H
Rofo; 2009 Jan; 181(1):60-6. PubMed ID: 19085691
[TBL] [Abstract][Full Text] [Related]
14. Progressive membrane phospholipid changes in first episode schizophrenia with high field magnetic resonance spectroscopy.
Miller J; Drost DJ; Jensen E; Manchanda R; Northcott S; Neufeld RW; Menon R; Rajakumar N; Pavlosky W; Densmore M; Schaefer B; Williamson P
Psychiatry Res; 2012 Jan; 201(1):25-33. PubMed ID: 22284150
[TBL] [Abstract][Full Text] [Related]
15. 31P NMR spectroscopy of phospholipid metabolites in postmortem schizophrenic brain.
Komoroski RA; Pearce JM; Mrak RE
Magn Reson Med; 2008 Mar; 59(3):469-74. PubMed ID: 18306399
[TBL] [Abstract][Full Text] [Related]
16. In vivo 31P NMR spectroscopy shows an increase in glycerophosphorylcholine concentration without alterations in mitochondrial function in the prefrontal cortex of medicated schizophrenic patients at rest.
Shirayama Y; Yano T; Takahashi K; Takahashi S; Ogino T
Eur J Neurosci; 2004 Aug; 20(3):749-56. PubMed ID: 15255985
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal 4.0 Tesla (31)P magnetic resonance spectroscopy changes in the anterior cingulate and left thalamus in first episode schizophrenia.
Miller J; Williamson P; Jensen JE; Manchanda R; Menon R; Neufeld R; Rajakumar N; Pavlosky W; Densmore M; Schaefer B; Drost DJ
Psychiatry Res; 2009 Aug; 173(2):155-7. PubMed ID: 19520552
[TBL] [Abstract][Full Text] [Related]
18. High-energy phosphate metabolism in the frontal lobes of patients with panic disorder detected by phase-encoded 31P-MRS.
Shioiri T; Kato T; Murashita J; Hamakawa H; Inubushi T; Takahashi S
Biol Psychiatry; 1996 Oct; 40(8):785-93. PubMed ID: 8894072
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of right thalamus and temporal cortex metabolite levels of drug-naive first-episode psychotic and chronic schizophrenia in patients].
Başoğlu C; Cetin M; Oner O; Ebrinç S; Semiz UB; Kandilcioğlu H; Silit E; Kizilkaya E
Turk Psikiyatri Derg; 2006; 17(2):85-91. PubMed ID: 16755408
[TBL] [Abstract][Full Text] [Related]
20. Multiregional 1H-MRSI of the hippocampus, thalamus, and basal ganglia in schizophrenia.
Ende G; Braus DF; Walter S; Weber-Fahr W; Henn FA
Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):9-15. PubMed ID: 12664307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
